Clinical trial
Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)
NCT03939013 is registered in ClinicalTrials.gov with Macfarlane Burnet Institute for Medical Research and Public Health Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)
- Lead sponsor
- Macfarlane Burnet Institute for Medical Research and Public Health Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 30, 2019
- Completion date
- December 20, 2020
- Enrollment
- 634 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.